Facilities Management - Life Cycle Asset Management Programme

Operating across more than 120 sites worldwide, this global pharmaceutical organisation embarked on a Life Cycle Asset Management Programme to bring clarity, structure, and consistency to its estate. Years of regional growth had created uneven data capture, fragmented asset information, and limited visibility of performance and risk—making it increasingly difficult for the leadership team to take informed, future-focused decisions.

The challenges were wide-ranging: incomplete and duplicated CAFM data, high-level criticality models offering little asset-specific insight, routine rather than strategic preventive maintenance, and no reliable way to forecast investment needs. These gaps eroded confidence, disrupted long-term planning and made it difficult to direct maintenance and capital expenditure where it mattered most.